retatrutide phase 2 trial results obesity study sees significant weight loss in drug study Effects of retatrutide on body

If anything on your vial label does not match your provider instructions, call the pharmacy before injecting

While there is plenty of noise and misinformation surrounding them, the truth is simple

August 9th, 2025: Lawsuits Mount Over Vision Loss Risks Linked to Ozempic, Wegovy, and Mounjaro New research has suggested a possible connection between GLP-1 receptor agonist drugsincluding Ozempic, Wegovy, and Mounjaroand heightened risks of severe eye conditions such as neovascular age-related macular degeneration (nAMD) and nonarteritic anterior ischemic optic neuropathy (NAION)

Those with a history of eating disorders or significant gastrointestinal disease may also face additional risks given the drug's potent appetite-suppressing and gastrointestinal effects

GLP-1 receptors are abundantly expressed in the pancreas, intestine, and central nervous system